| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4126652 | Otolaryngology - Head and Neck Surgery | 2007 | 6 Pages |
Abstract
The 5-year disease-specific survival rate was 80% for stage I-II, 44.8% for stage III, and 14.3% for stage IV disease. Surgery plus concomitant chemoradiotherapy led to a better survival rate than CCRT plus salvage surgery in patients with stage III-IV HPC.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Yung-An MD, Meng-Hung PhD, Chun-Hung MD, Hsien-Chang MD, Shang-Wen MD, Shih-Neng MD, Ji-An MD, Ming-Hsui MD,